CRO to lead discussion on “New Pathways to Approval” and engage with local talent to fill data science positions
CRO to lead discussion on “New Pathways to Approval” and engage with local talent to fill data science positions
WHAT: Rho, a full-service contract research organization (CRO), will host a PHUSE Single Day Event (SDE) for society members on the topic of “New Pathways to Approval,” being held on Thursday, December 5, at Rho headquarters in Research Triangle Park (RTP), North Carolina.
This event will discuss the study and program designs that use methodologies other than the traditional Phase I to III randomized trials, as well as the Food and Drug Administration’s (FDA) recently published guidance on the topic, which encourages sponsors to use non-traditional approaches such as master protocols, basket protocols, continuous drug development and historical cohorts instead of placebo.
Former Rho Co-CEO Russ Helms will welcome members to the event. Additionally, Rho’s David Hall, principle investigator and head of bioinformatics, will present “Clinical Trial of the Future: Technology-driven Innovation in Clinical Research” at 1:45 p.m., and Rho’s Jeff Abolafia, chief strategist, data standards, and co-SDE chair, will moderate the “Panel Discussion and Closing Remarks” at 3:30 p.m. Additional speakers include experts from the FDA, d-wise, Project Data Sphere, CDISC, Merck and MMS.
During the event, Rho will be discussing data science positions currently available.
WHO: Rho experts presenting at the PHUSE SDE include:
- Russ Helms, former co-CEO, Rho
- Welcome at 9:15 a.m.
- David Hall, principle investigator and head of bioinformatics, Rho
- Clinical Trial of the Future: Technology-driven Innovation in Clinical Research at 1:45 p.m.
- Jeff Abolafia, chief strategist, data standards, Rho, and co-SDE chair
- Moderating the Panel Discussion and Closing Remarks at 3:30 p.m.
WHEN: December 5, 2019, from 8:30 a.m.-4 p.m.
WHERE: Rho Inc.
2635 E NC Hwy 54
Durham, NC 27713
DETAILS: Attendees must be PHUSE members and can register for the free event here. Those interested in becoming a PHUSE member can apply at https://www.phuse.eu/become-a-
Attendance will be capped at 100 people, with 30 of these spots being open to Rho employees.
For media inquiries, please contact Kelly Maicon at Largemouth Communications, 919.741.9784, kmaicon@largemouthpr.com.
ABOUT: Rho, a privately-held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.
